Hwee Lin Wee (Hwee-Lin Wee)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Topics

Psychometric Properties

Multiple Myeloma

Top Venues

PharmacoEconomics - open

International journal of technology assessment in health care

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Health and quality of life outcomes

This page only lists publications with an associated author ORCID identifier.

Publications

Diana Beatriz S Bayani, Yihao Clement Lin, Chandramouli Nagarajan, Melissa Gaik-Ming Ooi, Allison Ching Yee Tso, John Cairns, Hwee Lin Wee
Modeling First-Line Daratumumab Use for Newly Diagnosed, Transplant-Ineligible, Multiple Myeloma: A Cost-Effectiveness and Risk Analysis for Healthcare Payers. PharmacoEconomics - open 8 (5) (2024)
Diana Beatriz S Bayani, Yihao Clement Lin, Chandramouli Nagarajan, Melissa Gaik-Ming Ooi, Allison Ching Yee Tso, John Cairns, Hwee Lin Wee
Modeling First-Line Daratumumab Use for Newly Diagnosed, Transplant-Ineligible, Multiple Myeloma: A Cost-Effectiveness and Risk Analysis for Healthcare Payers. PharmacoEconomics - open 8 (5) (2024)
Diana Beatriz S Bayani, Hwee Lin Wee
Value-based payment for high-cost treatments in Singapore: a qualitative study of stakeholders' perspectives. International journal of technology assessment in health care 40 (1) (2024)
Diana Beatriz S Bayani, Hwee Lin Wee
Value-based payment for high-cost treatments in Singapore: a qualitative study of stakeholders' perspectives. International journal of technology assessment in health care (2024)
Diana Beatriz S Bayani, Yihao Clement Lin, Chandramouli Nagarajan, Melissa Gaik-Ming Ooi, Allison Ching Yee Tso, John Cairns, Hwee Lin Wee
Modeling First-Line Daratumumab Use for Newly Diagnosed, Transplant-Ineligible, Multiple Myeloma: A Cost-Effectiveness and Risk Analysis for Healthcare Payers. PharmacoEconomics - open 8 (5) (2024)
Diana Beatriz S Bayani, Yihao Clement Lin, Chandramouli Nagarajan, Melissa Gaik-Ming Ooi, Allison Ching Yee Tso, John Cairns, Hwee Lin Wee
Modeling First-Line Daratumumab Use for Newly Diagnosed, Transplant-Ineligible, Multiple Myeloma: A Cost-Effectiveness and Risk Analysis for Healthcare Payers. PharmacoEconomics - open (2024)
Diana Beatriz S Bayani, Hwee Lin Wee
Implementing outcomes-based risk-sharing agreements: an integrative review of applications in blood cancer in the UK and beyond. Expert review of pharmacoeconomics & outcomes research (2023)
Sarin Kc, Lydia Wenxin Lin, Diana Beatriz Samson Bayani, Yaroslava Zemlyanska, Amanda Adler, Jeonghoon Ahn, Kelvin Chan, Dechen Choiphel, Anne Julienne Genuino-Marfori, Brendon Kearney, Yuehua Liu, Ryota Nakamura, Fiona Pearce, Shankar Prinja, Raoh-Fang Pwu, Asrul Akmal Shafie, Binyan Sui, Auliya Abdurrohim Suwantika, Sean Tunis, Hui-Min Wu, John Zalcberg, Kun Zhao, Wanrudee Isaranuwatchai, Yot Teerawattananon, Hwee Lin Wee
What, Where, and How to Collect Real-World Data and Generate Real-World Evidence to Support Drug Reimbursement Decision-Making in Asia: A reflection Into the Past and A Way Forward. International journal of health policy and management 12 (2023)
Diana Beatriz S Bayani, Yihao Clement Lin, Melissa Gaik-Ming Ooi, Allison Ching Yee Tso, Hwee Lin Wee
Real-world utilization and healthcare costs for multiple myeloma: A retrospective analysis of patients in Singapore. EJHaem 4 (4) (2023)
Tamra Lysaght, Gerald Owen Schaefer, Teck Chuan Voo, Hwee Lin Wee, Roy Joseph
Professional Oversight of Emergency-Use Interventions and Monitoring Systems: Ethical Guidance From the Singapore Experience of COVID-19. Journal of bioethical inquiry 19 (2) (2022)
Sarocha Chootipongchaivat, Xin Yi Wong, Kevin Ten Haaf, Mikael Hartman, Kelvin B Tan, Nicolien T van Ravesteyn, Hwee Lin Wee
Cost-effectiveness Analysis of Breast Cancer Screening Using Mammography in Singapore: A Modeling Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 30 (4) (2021)
Yilin Ning, Peh-Joo Ho, Nathalie C Støer, Ka Keat Lim, Hwee Lin Wee, Mikael Hartman, Marie Reilly, Chuen Seng Tan
A New Procedure to Assess When Estimates from the Cumulative Link Model Can Be Interpreted as Differences for Ordinal Scales in Quality of Life Studies. Clinical epidemiology 13 (2021)
Jerry Zeng Yang Wong, Jia Hui Chai, Yen Shing Yeoh, Nur Khaliesah Mohamed Riza, Jenny Liu, Yik-Ying Teo, Hwee Lin Wee, Mikael Hartman
Cost effectiveness analysis of a polygenic risk tailored breast cancer screening programme in Singapore. BMC health services research 21 (1) (2021)
Aravind Sesagiri Raamkumar, Soon Guan Tan, Hwee Lin Wee
Use of Health Belief Model-Based Deep Learning Classifiers for COVID-19 Social Media Content to Examine Public Perceptions of Physical Distancing: Model Development and Case Study. JMIR public health and surveillance 6 (3) (2020)
Xin Yi Wong, Andrew Qi Jun Lim, Qianyu Shen, John Whay Kuang Chia, Min Hoe Chew, Wah Siew Tan, Hwee Lin Wee
Patient preferences and predicted relative uptake for targeted therapies in metastatic colorectal cancer: a discrete choice experiment. Current medical research and opinion 36 (10) (2020)
Yin Bun Cheung, Khung Keong Yeo, Kok Joon Chong, Eric Yin Hao Khoo, Hwee Lin Wee
Measurement equivalence of the English, Chinese and Malay versions of the World Health Organization quality of life (WHOQOL-BREF) questionnaires. Health and quality of life outcomes 17 (1) (2019)
Ian Yi Han Ang, Sheryl Hui Xian Ng, Nabilah Rahman, Milawaty Nurjono, Tat Yean Tham, Sue-Anne Ee Shiow Toh, Hwee Lin Wee
Right-Site Care Programme with a community-based family medicine clinic in Singapore: secondary data analysis of its impact on mortality and healthcare utilisation. BMJ open 9 (12) (2019)
Hwee Lin Wee, Khung Keong Yeo, Kok Joon Chong, Eric Yin Hao Khoo, Yin Bun Cheung
Mean Rank, Equipercentile, and Regression Mapping of World Health Organization Quality of Life Brief (WHOQOL-BREF) to EuroQoL 5 Dimensions 5 Levels (EQ-5D-5L) Utilities. Medical decision making : an international journal of the Society for Medical Decision Making 38 (3) (2019)
Si Ming Fung, Xin Yi Wong, Shi Xun Lee, Hui Miao, Mikael Hartman, Hwee Lin Wee
Performance of Single-Nucleotide Polymorphisms in Breast Cancer Risk Prediction Models: A Systematic Review and Meta-analysis. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 28 (3) (2018)
Xin Yi Wong, Kok Joon Chong, Janine A van Til, Hwee Lin Wee
A qualitative study on Singaporean women's views towards breast cancer screening and Single Nucleotide Polymorphisms (SNPs) gene testing to guide personalised screening strategies. BMC cancer 17 (1) (2017)